These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35950033)

  • 21. Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC.
    Imanishi S; Naoi Y; Shimazu K; Shimoda M; Kagara N; Tanei T; Miyake T; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2019 Apr; 174(3):627-637. PubMed ID: 30607631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy-related prognostic signature for survival prediction of triple negative breast cancer.
    Yang Q; Sun K; Xia W; Li Y; Zhong M; Lei K
    PeerJ; 2022; 10():e12878. PubMed ID: 35186475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer.
    Qiu P; Guo Q; Pan K; Chen J; Lin J
    Front Oncol; 2022; 12():890242. PubMed ID: 36276158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target.
    Yang YS; Ren YX; Liu CL; Hao S; Xu XE; Jin X; Jiang YZ; Shao ZM
    Breast Cancer Res Treat; 2022 Jun; 193(2):319-330. PubMed ID: 35334008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
    Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
    Front Immunol; 2021; 12():749459. PubMed ID: 34603338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer.
    Zhu Y; Zhang J; Yu L; Xu S; Chen L; Wu K; Kong L; Lin W; Xue J; Wang Q; Lin Y; Chen X
    Front Oncol; 2022; 12():972969. PubMed ID: 36698419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and
    Telli ML; Chu C; Badve SS; Vinayak S; Silver DP; Isakoff SJ; Kaklamani V; Gradishar W; Stearns V; Connolly RM; Ford JM; Gruber JJ; Adams S; Garber J; Tung N; Neff C; Bernhisel R; Timms KM; Richardson AL
    Clin Cancer Res; 2020 Jun; 26(11):2704-2710. PubMed ID: 31796517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
    Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
    J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ferroptosis and triple-negative breast cancer: Potential therapeutic targets.
    Xu N; Li B; Liu Y; Yang C; Tang S; Cho WC; Huang Z
    Front Oncol; 2022; 12():1017041. PubMed ID: 36568247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer.
    Pan JW; Tan ZC; Ng PS; Zabidi MMA; Nur Fatin P; Teo JY; Hasan SN; Islam T; Teoh LY; Jamaris S; See MH; Yip CH; Rajadurai P; Looi LM; Taib NAM; Rueda OM; Caldas C; Chin SF; Lim J; Teo SH
    NPJ Breast Cancer; 2024 Jul; 10(1):60. PubMed ID: 39030225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
    Cui J; Jiang H
    Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis.
    Chen C; Lin CJ; Li SY; Hu X; Shao ZM
    Ann Transl Med; 2022 Oct; 10(20):1095. PubMed ID: 36388802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer.
    Su P; Peng Z; Xu B; Yang B; Jin F
    PeerJ; 2021; 9():e12383. PubMed ID: 34900411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prognostic Risk Signature of Two Autophagy-Related Genes for Predicting Triple-Negative Breast Cancer Outcomes.
    Yu B; Xing Z; Tian X; Feng R
    Breast Cancer (Dove Med Press); 2024; 16():529-544. PubMed ID: 39246674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Alternative mRNA Splicing Signature and a Novel Biomarker in Triple-Negative Breast Cancer.
    Liu Q; Wang X; Kong X; Yang X; Cheng R; Zhang W; Gao P; Chen L; Wang Z; Fang Y; Wang J
    DNA Cell Biol; 2020 Jun; 39(6):1051-1063. PubMed ID: 32379494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer.
    Peng W; Lin C; Jing S; Su G; Jin X; Di G; Shao Z
    Front Oncol; 2021; 11():746763. PubMed ID: 34604089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of immune-related prognostic biomarkers in triple-negative breast cancer.
    Song XQ; Shao ZM
    Transl Cancer Res; 2024 Apr; 13(4):1707-1720. PubMed ID: 38737702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel eight-gene Immune Cell-Associated Predictive Gene model to predict recurrence in triple-negative breast cancer.
    Sui XY; Shao ZM; Fan L
    Transl Cancer Res; 2023 Jul; 12(7):1727-1740. PubMed ID: 37588732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.